These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Jaeger J; Koczan D; Thiesen HJ; Ibrahim SM; Gross G; Spang R; Kunz M Clin Cancer Res; 2007 Feb; 13(3):806-15. PubMed ID: 17289871 [TBL] [Abstract][Full Text] [Related]
11. Molecular markers in melanoma. Kashani-Sabet M Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339 [TBL] [Abstract][Full Text] [Related]
12. Ataxia telangiectasia-mutated gene is a possible biomarker for discrimination of infiltrative deep penetrating nevi and metastatic vertical growth phase melanoma. Roesch A; Becker B; Bentink S; Spang R; Vogl A; Hagen I; Landthaler M; Vogt T Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2486-90. PubMed ID: 18006941 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements. Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744 [TBL] [Abstract][Full Text] [Related]
14. Tumor and inflammation markers in melanoma using tissue microarrays: a validation study. Jensen TO; Riber-Hansen R; Schmidt H; Hamilton-Dutoit SJ; Steiniche T Melanoma Res; 2011 Dec; 21(6):509-15. PubMed ID: 21946018 [TBL] [Abstract][Full Text] [Related]
15. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. Camp RL; Neumeister V; Rimm DL J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers. Bertucci F; Pages C; Finetti P; Rochaix P; Lamant L; Devilard E; Nguyen C; Houlgatte R; Birnbaum D; Xerri L; Brousset P Anticancer Res; 2007; 27(5A):3441-9. PubMed ID: 17970093 [TBL] [Abstract][Full Text] [Related]
18. Molecular biologic staging of lung cancer. D'Amico TA Ann Thorac Surg; 2008 Feb; 85(2):S737-42. PubMed ID: 18222207 [TBL] [Abstract][Full Text] [Related]
19. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472 [TBL] [Abstract][Full Text] [Related]
20. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma. Bolander A; Agnarsdóttir M; Wagenius G; Strömberg S; Pontén F; Ekman S; Brattström D; Larsson A; Einarsson R; Ullenhag G; Hesselius P; Bergqvist M Melanoma Res; 2008 Dec; 18(6):412-9. PubMed ID: 19011512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]